RAPP
Rapport Therapeutics, Inc. Common Stock
NASDAQHealthcareBiotechnologyUS
USD42.56
+2.35 (+5.84%)
Rating:C+
Company Profile
CEO
Abraham N. Ceesay
IPO Date
2024-06-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$39.96
Prev. Close
$40.21
Day Low
$39.93
Day High
$43.29
52W Low
$13.62
52W High
$44.28
Market Cap
$1.55B
Volume
0.26M